The Centers for Disease Control and Prevention (CDC) now recommends that American adults over the age of 50 receive the ...

V116 (PCV21) was more cost-effective than PCV20 alone and PCV15 plus PPSV23 for the prevention of adult pneumococcal disease.

Vaccines do not necessarily offer complete immunity to a person; rather, they help prevent infections and reduce the severity ...